Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s Disease: progress and problems on the road to therapeutics[J]. Sci, 2002, 297 (5 580): 353-356.
Mathis CA, Wang Y, Klunk WE. Imaging betaamyloid plaques and neurofibrillary tangles in the aging human brain[J]. Curr Pharm Des, 2004, 10 (13): 1 469-1 492.
[6]
Nordberg A. PET imaging of amyloid in Alzheimer’s Disease[J]. Lancet Neurol, 2004, 3 (9): 519-527.
[7]
Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles (NFTs) and betaamyloid plaques (APs) in the brains of living patients with Alzheimer’s Disease[J]. 2002, Am J Geriatr Psychiatry, 10 (1): 24-35.
[8]
Small GW, Kepe V, Ercoli LM, et al. PET of brain amyloid and tau in mild cognitive impairment[J]. N Engl J Med, 2006, 355(25): 2 652-2 663.
[9]
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s Disease with pittsburgh compound-B[J]. Ann Neurol, 2004, 55 (3): 306-319.
[10]
Engler H, Forsberg A, Almkvist O, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer’s Disease[J]. Brain, 2006, 129 (11): 2 856-2 866.
[11]
Verhoeff NPLG, Wilson AA, Takeshita S, et al. In-vivo imaging of Alzheimer’s Disease beta-amyloid with [11C]SB-13 PET[J]. Am J Geriatr Psychiatry, 2004, 12(6): 584-595.
[12]
Ono M, Wilson A, Nobrega J, et al. C11 labeled stilbene derivatives as Aβ aggregate-specific PET imaging agents for Alzheimer’s Disease[J]. Nucl Med Biol, 2003, 30 (6)： 565-571.
[13]
Kudo Y, Okamura N, Furumoto S, et al. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain[J]. J Nucl Med, 2007, 48 (4): 553-561.
Zhuang ZP, Kung MP, Hou C, et al. Biphenyls labeled with technetium-99m for imaging β-amyloid plaques in the brain[J]. Nucl Med Biol, 2005, 32 (2): 171-184.
[16]
Ono M, Watanabe R, Kawashima H, et al. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer’s brains[J]. Bioorg Med Chem, 2009, 17(5): 2 069-2 076.
[17]
Ono M, Yoshida N, Ishibashi K, et al. Radioiodinated flavones for in vivo imaging of β-amyloid plaques in the brain[J]. J Med Chem, 2005, 48 (23): 7 253-7 260.
[18]
Alberto R, Schibli R, Egli A, et al. A novel Organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99Tcm(OH2）3(CO)3]+ from [99TcmO4]- in aqueous solution and its reaction with a bifunctional ligand[J]. J Am Chem Soc, 1998, 120 (31): 7 987-7 988.
[19]
Klunk WE, Jacob RF, Preston MR. Quantifying amyloid β-Peptide (Aβ) aggregation using the congo redAβ (CR-Aβ) spectrophotometric assay[J]. Anal Chem, 1999, 266 (1): 66-76.
[20]
LeVine H, Thioflavine T. Interaction with synthetic Alzheimer’s Disease beta-amyloid peptides: detection of amyloid aggregation in solution[J]. Protein Sci, 1993, 2 (3): 404-410.
[21]
Ono M, Maya Y, Haratake M, et al. Synthesis and characterization of styrylchromone derivatives as betaamyloid imaging agents[J]. Bioorg Med Chem, 2007, 15 (1): 444-450.
